Exchange: NASDAQ·Updated 07:30 PM EST

MLYS News

News
all
press releases
Mineralys Therapeutics, Inc. (MLYS) - What Are Researchers Thinking About This Stock?
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned an average recommendation of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold reco...
MarketBeat
Mineralys Therapeutics, Inc. (MLYS) - What Are Researchers Thinking About This Stock?
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned an average recommendation of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold reco...
MarketBeat
More News
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 1-Year Low - Time to Sell...
MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Shares Climb 4.4% - Here's Why...
MarketBeat
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger...
Yahoo! Finance: News
Key PointsThe Chief Medical Officer of Mineralys Therapeutics reported selling 14,474 Common Stock shares across multiple transactions on June 15 and June 17, 2026, for a total value of approximately $350,000...
Nasdaq News: Markets
Mineralys Therapeutics (MLYS) Shares Encouraging Data for Lorundrostat Clinical Efficacy...
Yahoo! Finance: News
Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rat...
MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-mineralys-therapeutics-inc-stock...
MarketBeat
Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 8.2% - Should You Buy...
MarketBeat
Jennison Associates LLC grew its holdings in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 234.4% in the fourth quarter, according to its most recent filing with the...
MarketBeat

Advertisement|Remove ads.